CoChat

The method of minimization for allocation to clinical trials

Scott, Neil W, McPherson, Gladys C, Ramsay, Craig R, Campbell, Marion K · 2002 · Controlled Clinical Trials

The DOI matches its Crossref record; 41 of the 44 references it cites were found in a registry or an index.

Abstract

Minimization is a largely nonrandom method of treatment allocation for clinical trials. We conducted a systematic literature search to determine its advantages and disadvantages compared with other allocation methods. Minimization was originally proposed by Taves and by Pocock and Simon. The latter paper introduces a family of allocation methods of which Taves' method is the simplest example. Minimization aims to ensure treatment arms are balanced with respect to predefined patient factors as well as for the number of patients in each group. Further extensions of the method have also been proposed by other authors. Simulation studies show that minimization provides better balanced treatment groups when compared with restricted or unrestricted randomization and that it can incorporate more prognostic factors than stratified randomization methods such as permuted blocks within strata. Some more computationally complex methods may give an even better performance. Concerns over the use of minimization have centered on the fact that treatment assignments may be predicted with certainty in some situations and on the implications for the analysis methods used. It has been suggested that adjustment should always be made for minimization factors when analyzing trials where minimization is the allocation method used. The use of minimization may sometimes result in added organizational complexity compared with other methods. Minimization has been recommended by many commentators for use in clinical trials. Despite this it is still rarely used in practice. From the evidence presented in this review, we believe minimization to be a highly effective allocation method and recommend its wider adoption in the conduct of randomized controlled trials.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0197-2456(02)00242-8

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 6

  1. Day, 1999, Commentary, BMJ, 319, 947
  2. Brown, 1980, Designing for cancer clinical trials, Cancer Treatment Reports, 64, 499
  3. Campbell, 2001, Simple randomisation or minimisation, Control Clin Trials, 22, 87S
  4. Buyse, 2000, Centralized treatment allocation in comparative clinical trials, Applied Clinical Trials, 9, 32
  5. Vaughan Reed, 1988, Practical experience of minimisation in clinical trials, Pharmaceutical Medicine, 3, 349
  6. McPherson, 2002, Minimisation, Control Clin Trials, 23, 66S

Cited by

See all 651

Metadata

Authors
Scott, N. W., McPherson, G. C., Ramsay, C. R., & Campbell, M. K.
Affiliations
University of Aberdeen (GB)
Corresponding author
Scott, Neil W
Venue
Controlled Clinical Trials
Publisher
Elsevier BV
Published
2002-12
Volume
23
Issue
6
Pages
662-674
ISSN
0197-2456 (ISSN-L)
OpenAlex
W2108361431
Cited by
651
References
44
Citations by year
2026: 21 · 2025: 32 · 2024: 32 · 2023: 51 · 2022: 35 · 2021: 47 · 2020: 31 · 2019: 45 · 2018: 38 · 2017: 33 · 2016: 34 · 2015: 24 · 2014: 34 · 2013: 32 · 2012: 34
FWCI
7.67
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Controlled Clinical Trials (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
  • Social Sciences › Decision Sciences › Management Science and Operations Research › Optimal Experimental Design Methods
Keywords
minimization, treatment allocation, randomization methods, prognostic factors, stratified randomization, restricted randomization, randomized controlled trials
MeSH terms
Clinical Trials as Topic, Humans, Random Allocation, Research Design

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The method of minimization for allocation to clinical trials. https://app.cochat.ai/papers/10.1016/s0197-2456(02)00242-8
The paper
Scott, N. W., McPherson, G. C., Ramsay, C. R., & Campbell, M. K. (2002). The method of minimization for allocation to clinical trials. Controlled Clinical Trials. https://doi.org/10.1016/s0197-2456(02)00242-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.